Identifying People at a High Risk of Developing Pancreatic Cancer

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2012 Dec 11

PMID 23222481

Citations 63

Authors

Alison P Klein

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is a leading cause of cancer death, and it has the poorest prognosis of any major tumour type. Familial pancreatic cancer registries are important for investigating the genetic aetiology of this devastating disease. Using data from our familial pancreatic cancer registry and other registries, this Review discusses the usefulness of family registries in the study of pancreatic and other cancers, and also how such registries provide a unique opportunity for laboratory, population and clinical research.

Citing Articles

Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC).

Jacobs M, Stoffel E Fam Cancer. 2024; 23(3):221-232.

PMID: 38573398 DOI: 10.1007/s10689-024-00372-5.

Management of Metastatic Pancreatic Cancer-Comparison of Global Guidelines over the Last 5 Years.

Pajewska M, Partyka O, Czerw A, Deptala A, Cipora E, Gaska I Cancers (Basel). 2023; 15(17).

PMID: 37686675 PMC: 10486352. DOI: 10.3390/cancers15174400.

Mechanisms of development and progression of pancreatic neoplasms.

Furukawa T Pathol Int. 2022; 72(11):529-540.

PMID: 36161420 PMC: 9828726. DOI: 10.1111/pin.13272.

The current state of molecular profiling in gastrointestinal malignancies.

Mukherji R, Yin C, Hameed R, Alqahtani A, Kulasekaran M, He A Biol Direct. 2022; 17(1):15.

PMID: 35668531 PMC: 9172079. DOI: 10.1186/s13062-022-00322-0.

Design, synthesis and biological evaluation of -arylsulfonyl carbazoles as novel anticancer agents.

You X, Zhu D, Lu W, Sun Y, Qiao S, Luo B RSC Adv. 2022; 8(31):17183-17190.

PMID: 35539273 PMC: 9080423. DOI: 10.1039/c8ra02939c.

References

James T, Sheldon D, Rajput A, Kuvshinoff B, Javle M, Nava H . Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004; 101(12):2722-6. DOI: 10.1002/cncr.20700. View

Witt H, Luck W, Hennies H, Classen M, Kage A, Lass U . Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000; 25(2):213-6. DOI: 10.1038/76088. View

Bryant H, Schultz N, Thomas H, Parker K, Flower D, Lopez E . Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005; 434(7035):913-7. DOI: 10.1038/nature03443. View

Cleary S, Gryfe R, Guindi M, Greig P, Smith L, MacKenzie R . Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004; 198(5):722-31. DOI: 10.1016/j.jamcollsurg.2004.01.008. View

Couch F, Johnson M, Rabe K, Brune K, de Andrade M, Goggins M . The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(2):342-6. DOI: 10.1158/1055-9965.EPI-06-0783. View

Slater E, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N . PALB2 mutations in European familial pancreatic cancer families. Clin Genet. 2010; 78(5):490-4. DOI: 10.1111/j.1399-0004.2010.01425.x. View

Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B . Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467(7319):1114-7. PMC: 3148940. DOI: 10.1038/nature09515. View

Iodice S, Gandini S, Maisonneuve P, Lowenfels A . Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393(4):535-45. DOI: 10.1007/s00423-007-0266-2. View

Petersen G, Hruban R . Familial pancreatic cancer: where are we in 2003?. J Natl Cancer Inst. 2003; 95(3):180-1. DOI: 10.1093/jnci/95.3.180. View

10.

Macdermott R, Kramer P . Adenocarcinoma of the pancreas in four siblings. Gastroenterology. 1973; 65(1):137-9. View

11.

Wang W, Chen S, Brune K, Hruban R, Parmigiani G, Klein A . PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol. 2007; 25(11):1417-22. PMC: 2267288. DOI: 10.1200/JCO.2006.09.2452. View

12.

Goggins M, Lietman A, Miller R, Yeo C, Jaffee E, Coleman J . Use and benefits of a Web site for pancreatic cancer. JAMA. 1998; 280(15):1309-10. DOI: 10.1001/jama.280.15.1309-a. View

13.

Canto M, Goggins M, Yeo C, Griffin C, Axilbund J, Brune K . Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004; 2(7):606-21. DOI: 10.1016/s1542-3565(04)00244-7. View

14.

Canto M, Hruban R, Fishman E, Kamel I, Schulick R, Zhang Z . Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012; 142(4):796-804. PMC: 3321068. DOI: 10.1053/j.gastro.2012.01.005. View

15.

Price T, Payne R, Oberleitner M . Familial pancreatic cancer in south Louisiana. Cancer Nurs. 1996; 19(4):275-82. DOI: 10.1097/00002820-199608000-00003. View

16.

Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C . Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81(24):1879-86. DOI: 10.1093/jnci/81.24.1879. View

17.

Brune K, Lau B, Palmisano E, Canto M, Goggins M, Hruban R . Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst. 2010; 102(2):119-26. PMC: 2808346. DOI: 10.1093/jnci/djp466. View

18.

Klein A, Hruban R, Brune K, Petersen G, Goggins M . Familial pancreatic cancer. Cancer J. 2001; 7(4):266-73. View

19.

Klein A, Brune K, Petersen G, Goggins M, Tersmette A, Offerhaus G . Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004; 64(7):2634-8. DOI: 10.1158/0008-5472.can-03-3823. View

20.

Ghadirian P, Simard A, Baillargeon J . Cancer of the pancreas in two brothers and one sister. Int J Pancreatol. 1987; 2(5-6):383-91. DOI: 10.1007/BF02788437. View